Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by equities research analysts at Royal Bank Of Canada from a “hold” rating to a “moderate buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other analysts have also recently issued reports on TECH. UBS Group lowered their target price on shares of Bio-Techne from […] - 2025-09-05 05:36:53
Charles Schwab Investment Management Inc. lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,511,260 shares of the biotechnology company’s stock after buying an additional 45,570 shares during the quarter. […] - 2025-08-13 05:12:55
Cwm LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 6.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,927 shares of the biotechnology company’s stock after selling 786 shares during the quarter. Cwm LLC’s holdings in Bio-Techne […] - 2025-07-24 04:47:00
Signaturefd LLC decreased its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,690 shares of the biotechnology company’s stock after selling 293 shares during the quarter. Signaturefd LLC’s holdings in Bio-Techne were […] - 2025-07-21 05:43:00
Mutual of America Capital Management LLC raised its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 29.8% in the 1st quarter, HoldingsChannel reports. The fund owned 55,493 shares of the biotechnology company’s stock after acquiring an additional 12,740 shares during the period. Mutual of America Capital Management LLC’s holdings in Bio-Techne were worth $3,254,000 […] - 2025-07-18 05:16:49
Xponance Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,540 shares of the biotechnology company’s stock after purchasing an additional 619 shares during the period. Xponance […] - 2025-07-16 06:24:53
Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 20.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 132,742 shares of the biotechnology company’s stock after purchasing an additional 22,259 shares during the quarter. Cerity Partners LLC’s holdings in Bio-Techne were worth $7,783,000 at the end […] - 2025-07-16 05:38:08
DekaBank Deutsche Girozentrale lowered its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,926 shares of the biotechnology company’s stock after selling 261 shares during the quarter. DekaBank Deutsche […] - 2025-07-14 05:34:48
Vontobel Holding Ltd. lessened its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 5.1% during the first quarter, HoldingsChannel reports. The fund owned 4,960 shares of the biotechnology company’s stock after selling 269 shares during the period. Vontobel Holding Ltd.’s holdings in Bio-Techne were worth $291,000 at the end of the most […] - 2025-07-09 05:02:49
GAMMA Investing LLC reduced its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 38.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,795 shares of the biotechnology company’s stock after selling 1,101 shares during the quarter. GAMMA Investing LLC’s holdings in […] - 2025-07-07 04:17:11
Janney Montgomery Scott LLC raised its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% during the 1st quarter, Holdings Channel reports. The firm owned 11,210 shares of the biotechnology company’s stock after acquiring an additional 490 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Bio-Techne were worth $657,000 at the end […] - 2025-07-02 05:43:07
Diversified Trust Co grew its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 10.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,824 shares of the biotechnology company’s stock after buying an additional 1,260 shares during the quarter. […] - 2025-06-30 05:10:55
Bessemer Group Inc. decreased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 75.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,748 shares of the biotechnology company’s stock after selling 61,323 shares during the quarter. Bessemer […] - 2025-06-30 04:38:49
Chevy Chase Trust Holdings LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,909 shares of the biotechnology company’s stock after selling 2,582 shares during the quarter. Chevy Chase Trust […] - 2025-06-27 05:12:48
Retirement Systems of Alabama lessened its stake in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.2% in the first quarter, HoldingsChannel reports. The firm owned 33,972 shares of the biotechnology company’s stock after selling 430 shares during the period. Retirement Systems of Alabama’s holdings in Bio-Techne were worth $1,992,000 at the end of the most […] - 2025-06-26 06:06:47
Oppenheimer Asset Management Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% in the first quarter, Holdings Channel reports. The firm owned 67,166 shares of the biotechnology company’s stock after acquiring an additional 2,929 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Bio-Techne were worth $3,938,000 at […] - 2025-06-26 05:16:55
Exchange Traded Concepts LLC lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 21.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,803 shares of the biotechnology company’s stock after buying an additional 490 shares during the quarter. Exchange […] - 2025-06-24 04:36:51
CX Institutional acquired a new position in Bio-Techne Corp (NASDAQ:TECH – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 459 shares of the biotechnology company’s stock, valued at approximately $27,000. Several other large investors also […] - 2025-06-19 04:52:57
Bio-Techne Corp (NASDAQ:TECH – Get Free Report) has earned an average recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts […] - 2025-06-18 06:12:46
Mn Services Vermogensbeheer B.V. trimmed its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,200 shares of the biotechnology company’s stock after selling 6,200 shares during the quarter. Mn Services […] - 2025-06-18 05:32:53
Wall Street Zen lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a research note issued to investors on Sunday. Several other analysts have also commented on the stock. Citigroup lowered their price target on shares of Bio-Techne from $80.00 to $70.00 and set a “neutral” rating […] - 2025-06-09 03:44:45
Rhumbline Advisers lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.1% during the first quarter, Holdings Channel.com reports. The institutional investor owned 300,474 shares of the biotechnology company’s stock after acquiring an additional 39,345 shares during the quarter. Rhumbline Advisers’ holdings in Bio-Techne were worth $17,617,000 as of its most recent filing […] - 2025-06-08 05:35:05
Squarepoint Ops LLC boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 113.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,060 shares of the biotechnology company’s stock after buying an additional 4,816 shares during […] - 2025-06-03 05:06:58
Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 56,666 shares of the biotechnology company’s stock, valued at approximately $4,082,000. Other hedge funds and other institutional investors […] - 2025-06-02 05:36:54
Two Sigma Advisers LP trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,900 shares of the biotechnology company’s stock after selling 900 shares during the quarter. Two Sigma Advisers […] - 2025-06-01 05:44:50
Cetera Investment Advisers lessened its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,857 shares of the biotechnology company’s stock after selling 887 shares during the quarter. Cetera Investment Advisers’ holdings in Bio-Techne were worth $1,430,000 at the end of the most recent […] - 2025-05-22 04:52:55
Bank of America Corp DE cut its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 37.0% during the 4th quarter, Holdings Channel reports. The fund owned 516,549 shares of the biotechnology company’s stock after selling 303,523 shares during the period. Bank of America Corp DE’s holdings in Bio-Techne were worth $37,207,000 as of its […] - 2025-05-16 05:31:04
Mercer Global Advisors Inc. ADV decreased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 4,028 shares of the biotechnology company’s stock after selling 751 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Bio-Techne were worth $290,000 at the […] - 2025-05-16 04:49:06
Bio-Techne (NASDAQ:TECH – Get Free Report) declared that its board has initiated a share buyback program on Wednesday, May 7th, RTT News reports. The company plans to buyback $500.00 million in outstanding shares. This buyback authorization permits the biotechnology company to repurchase up to 6.5% of its shares through open market purchases. Shares buyback programs […] - 2025-05-09 02:15:42
Representative April McClain Delaney (D-Maryland) recently bought shares of Bio-Techne Co. (NASDAQ:TECH). In a filing disclosed on May 02nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Bio-Techne stock on April 9th. Representative April McClain Delaney also recently made the following trade(s): Sold $1,001 – $15,000 in shares of Toro (NYSE:TTC) […] - 2025-05-06 03:05:00
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.
0.0%